Wright Jason D, Fiorelli Jessica, Schiff Peter B, Burke William M, Kansler Amanda L, Cohen Carmel J, Herzog Thomas J
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.
Cancer. 2009 Mar 15;115(6):1276-85. doi: 10.1002/cncr.24160.
Black women with endometrial cancer have been more likely to die than white patients. The authors examined factors associated with the poor outcome for black women with uterine corpus tumors and analyzed whether these characteristics have changed over time based on year of diagnosis.
The authors examined women with uterine neoplasms recorded from 1988-2004 in the Surveillance, Epidemiology and End Results (SEER) Database. The authors developed Cox proportional hazards models to examine the effect of race on survival and stratified women by year of diagnosis into 3 groups: 1988-1993, 1994-1998, 1999-2004.
A total of 80,915 patients including 5564 (7%) black women were identified. Black patients were significantly younger, had more advanced stage tumors, and had more aggressive, nonendometrioid histologic variants (P<.001). Black women were 60% more likely to die from their tumors than white women when matched for other prognostic variables (hazards ratio, 1.60; 95% confidence interval, 1.51-1.69). For each of the 3 time periods, survival was worse for blacks even when stratified by stage and histology. Over time, the incidence of serous and clear-cell tumors increased, and the use of radiation decreased for both races. Staging lymphadenectomy was performed more commonly in both blacks (45%) and whites (48%) who had been treated more recently.
Black women with uterine corpus tumors were more likely to die from their disease. This survival difference has persisted over time. The clinical characteristics of blacks and whites have remained relatively constant. The proportion of women who undergo surgical staging has increased with time and was well matched between races.
患有子宫内膜癌的黑人女性比白人患者更易死亡。作者研究了与子宫体肿瘤黑人女性预后不良相关的因素,并分析了这些特征是否随诊断年份的推移而发生变化。
作者研究了1988年至2004年监测、流行病学和最终结果(SEER)数据库中记录的子宫肿瘤女性患者。作者建立了Cox比例风险模型,以研究种族对生存的影响,并按诊断年份将女性分为3组:1988 - 1993年、1994 - 1998年、1999 - 2004年。
共识别出80915例患者,其中包括5564例(7%)黑人女性。黑人患者明显更年轻,肿瘤分期更晚,且具有更多侵袭性的非子宫内膜样组织学变体(P<0.001)。在匹配其他预后变量时,黑人女性死于肿瘤的可能性比白人女性高60%(风险比,1.60;95%置信区间,1.51 - 1.69)。在三个时间段中的每一个时间段,即使按分期和组织学分层,黑人的生存率也更差。随着时间的推移,浆液性和透明细胞肿瘤的发病率增加,两个种族的放疗使用率均下降。近期接受治疗的黑人(45%)和白人(48%)中,分期淋巴结清扫术的实施更为普遍。
患有子宫体肿瘤的黑人女性更易死于该病。这种生存差异一直存在。黑人和白人的临床特征相对保持不变。接受手术分期的女性比例随时间增加,且种族之间匹配良好。